Sex-differences in circulating biomarkers during acute myocardial infarction: An analysis from the SWEDEHEART registry
暂无分享,去创建一个
B. Lindahl | G. Marko‐Varga | M. Rezeli | T. Jernberg | D. Erlinge | N. Johnston | J. Spaak | T. Baron | L. Lindhagen | K. Eggers | M. Hjort
[1] D. Levy,et al. Sex Differences in Circulating Biomarkers of Cardiovascular Disease. , 2019, Journal of the American College of Cardiology.
[2] Jeroen J. Bax,et al. Fourth universal definition of myocardial infarction (2018). , 2018, European heart journal.
[3] D. Kimenai,et al. Sex-Related Aspects of Biomarkers in Cardiac Disease. , 2018, Advances in experimental medicine and biology.
[4] G. Savarese,et al. Sex Differences in Heart Failure. , 2018, Advances in experimental medicine and biology.
[5] V. Taqueti. Sex Differences in the Coronary System. , 2018, Advances in experimental medicine and biology.
[6] B. Lindahl,et al. Quantitation of 87 Proteins by nLC-MRM/MS in Human Plasma: Workflow for Large-Scale Analysis of Biobank Samples. , 2017, Journal of proteome research.
[7] R. Schnabel,et al. Predictors of leptin concentration and association with cardiovascular risk in patients with coronary artery disease: results from the AtheroGene study , 2017, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[8] K. Malmberg,et al. Elevated levels of adipokines predict outcome after acute myocardial infarction: A long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort , 2017, Diabetes & vascular disease research.
[9] A. Khera,et al. Sex-Based Differences in Cardiometabolic Biomarkers , 2017, Circulation.
[10] A. Mayr,et al. Fibroblast growth factor 23 as novel biomarker for early risk stratification after ST-elevation myocardial infarction , 2016, Heart.
[11] H. Nathoe,et al. Severity of stable coronary artery disease and its biomarkers differ between men and women undergoing angiography. , 2015, Atherosclerosis.
[12] L. Tokgozoglu,et al. Trends in Gender Differences in Cardiac Care and Outcome After Acute Myocardial Infarction in Western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) , 2015, Journal of the American Heart Association.
[13] The Uniprot Consortium,et al. UniProt: a hub for protein information , 2014, Nucleic Acids Res..
[14] G. Schuler,et al. Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial , 2014, Critical Care.
[15] B. Lindahl,et al. Cardiac troponin I levels in patients with non-ST-elevation acute coronary syndrome-the importance of gender. , 2014, American heart journal.
[16] J. Stenvang,et al. Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability , 2014, PloS one.
[17] W. März,et al. Copper, ceruloplasmin, and long-term cardiovascular and total mortality (The Ludwigshafen Risk and Cardiovascular Health Study) , 2014, Free radical research.
[18] D. Fairweather. Sex Differences in Inflammation During Atherosclerosis , 2014, Clinical Medicine Insights. Cardiology.
[19] E. Vittinghoff,et al. Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study. , 2011, Atherosclerosis.
[20] Martin Lundberg,et al. Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood , 2011, Nucleic acids research.
[21] L. Wallentin,et al. Abstract 1428: Statin Use After Myocardial Iinfarction Improves Survival in Nearly All With Renal Dysfunction: Data From the Swedish Web-system for Enhancement and Development of Evidence-based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) , 2009 .
[22] D. Clegg,et al. Sexual Dimorphism in Body Fat Distribution and Risk for Cardiovascular Diseases , 2009, Journal of cardiovascular translational research.
[23] E. Barrett-Connor,et al. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. , 2006, American journal of epidemiology.
[24] A. Hamsten,et al. Lower serum concentration of matrix metalloproteinase‐3 in the acute stage of myocardial infarction , 2006, Journal of internal medicine.
[25] W. Rathmann,et al. Sex differences in the relation of body composition to markers of inflammation. , 2006, Atherosclerosis.
[26] R. Califf,et al. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. , 2005, JAMA.
[27] Robert P. Giugliano,et al. Differential Expression of Cardiac Biomarkers by Gender in Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy–Thrombolysis In Myocardial Infarction 18) Substudy , 2004, Circulation.